Clinical Trials Browser

Phase NA × Recruiting × Fulvestrant × Clear all

NCT06856200 2025-03-04

A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer

Phase NA Recruiting

Advanced HR - Positive, HER2 - Negative Breast Cancer